Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,011,000 | 7,028,000 | 5,974,000 | 4,162,000 | 2,306,000 |
| Depreciation Amortization | 1,369,000 | N/A | 4,146,000 | 2,791,000 | 1,282,000 |
| Income taxes - deferred | 341,000 | N/A | 1,029,000 | 672,000 | 372,000 |
| Other Working Capital | -2,151,000 | -3,317,000 | -4,228,000 | -3,590,000 | -2,807,000 |
| Other Operating Activity | -28,000 | 8,186,000 | 819,000 | 579,000 | 551,000 |
| Operating Cash Flow | $1,542,000 | $11,897,000 | $7,740,000 | $4,614,000 | $1,704,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,000 | -333,000 | -146,000 | -110,000 | 5,000 |
| PPE Investments | 144,000 | -2,130,000 | -748,000 | -600,000 | -185,000 |
| Net Acquisitions | -622,000 | -7,625,000 | -7,277,000 | -6,909,000 | -6,131,000 |
| Purchase Of Investment | N/A | -264,000 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 166,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -324,000 | -517,000 | -923,000 | -722,000 | -246,000 |
| Other Investing Activity | -324,000 | -598,000 | -923,000 | -722,000 | -246,000 |
| Investing Cash Flow | $-772,000 | $-10,784,000 | $-9,094,000 | $-8,341,000 | $-6,557,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,661,000 | 451,000 | 2,692,000 | 3,020,000 | 4,998,000 |
| Debt Issued | N/A | 4,596,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -3,086,000 | N/A | N/A | N/A |
| Common Stock Repurchased | -184,000 | -6,071,000 | -2,417,000 | -542,000 | 82,000 |
| Dividend Paid | -6,475,000 | -6,647,000 | -6,643,000 | -6,643,000 | -6,643,000 |
| Other Financing Activity | -29,000 | 1,581,000 | -33,000 | -40,000 | -192,000 |
| Financing Cash Flow | $-1,027,000 | $-9,176,000 | $-6,401,000 | $-4,205,000 | $-1,755,000 |
| Exchange Rate Effect | 40,000 | -286,000 | 60,000 | 127,000 | 58,000 |
| Beginning Cash Position | 4,674,000 | 13,023,000 | 13,023,000 | 13,023,000 | 13,023,000 |
| End Cash Position | 4,457,000 | 4,674,000 | 5,328,000 | 5,218,000 | 6,473,000 |
| Net Cash Flow | $-217,000 | $-8,349,000 | $-7,695,000 | $-7,805,000 | $-6,550,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,542,000 | 11,897,000 | 7,740,000 | 4,614,000 | 1,704,000 |
| Capital Expenditure | -385,000 | -2,367,000 | -1,614,000 | -1,035,000 | -469,000 |
| Free Cash Flow | 1,157,000 | 9,530,000 | 6,126,000 | 3,579,000 | 1,235,000 |